<p>肩部创新公司（NYSE:SI - 获取免费报告）首席财务官杰弗里·波因茨于 12 月 11 日（星期四）购买了 995 股该公司的股票。股票的平均购买价格为每股 14.65 美元，总价值为 14,576.75 美元。交易完成后，首席财务官直接持有 53,440 股公司的股票，价值 782,896 美元。这笔交易代表了其持股比例的 1.90% 的增加。此次购买在提交给证券交易委员会的文件中披露，相关文件可通过此链接获取。</p>
<p>获取 <strong>肩部创新</strong> 的提醒：</p>
<h2>肩部创新价格表现</h2>
<ul>
<li>3 只矿业股票有望受益于贵金属热潮</li>
</ul>
<p>周一，NYSE SI 上涨 0.12 美元，达到 14.49 美元。该股票的交易量为 36,567 股，而其平均交易量为 112,664 股。该公司的 50 日移动平均线为 13.43 美元。肩部创新公司 52 周最低价为 10.92 美元，52 周最高价为 17.94 美元。</p>
<p>肩部创新（NYSE:SI - 获取免费报告）最近于 11 月 11 日（星期二）发布了季度财报。公司报告本季度每股收益为（0.48 美元），低于市场共识预期的（0.37 美元），差距为（0.11 美元）。该公司本季度的收入为 1176 万美元，而分析师预期为 999 万美元。研究分析师平均预计肩部创新公司本年度每股收益为-0.56 美元。</p>
<h2>对肩部创新的对冲基金看法</h2>
<ul>
<li>MarketBeat 周回顾 – 7/8 - 7/12</li>
</ul>
<p>几家机构投资者和对冲基金最近对该公司的持仓进行了调整。Federated Hermes Inc.在第三季度购买了肩部创新的新股份，价值 251 万美元。斯坦福大学董事会在第三季度购买了肩部创新的新股份，价值约 17 万美元。Rhumbline Advisers 在第三季度购买了肩部创新的新股份，价值约 5.4 万美元。TimesSquare Capital Management LLC 在第三季度购买了肩部创新的新股份，价值约 479.9 万美元。最后，先锋集团在第三季度购买了肩部创新的新股份，价值约 183.6 万美元。</p>
<h2>分析师评级上调和下调</h2>
<p>多家券商最近对 SI 发布了报告。BTIG 研究在 9 月 9 日的研究报告中重申了 “买入” 评级，并设定了 23.00 美元的目标价。Piper Sandler 在 11 月 12 日的研究报告中重申了 “增持” 评级，并设定了 18.00 美元的目标价。华尔街 Zen 在 10 月 11 日的报告中将肩部创新的评级从 “卖出” 上调至 “持有”。杰富瑞金融集团在 8 月 25 日的研究报告中开始覆盖肩部创新的股票，设定了 “买入” 评级和 19.00 美元的目标价。最后，Zacks 研究在 8 月 26 日的研究报告中将肩部创新的评级上调至 “持有”。五位投资分析师对该股票给予了 “买入” 评级，一位给予了 “持有” 评级，一位给予了 “卖出” 评级。根据 MarketBeat 的数据，肩部创新目前的平均评级为 “适度买入”，平均目标价为 20.60 美元。</p>
<ul>
<li>新主题公园强者：合并创造行业领先股票</li>
</ul>
<p><strong>查看我们最新的 SI 股票报告</strong></p>
<h2>肩部创新公司简介</h2>
<p>（获取免费报告）</p>
<p>我们是一家商业阶段的医疗技术公司，专注于转变肩部外科护理市场。我们目前提供用于肩关节置换术的先进植入系统。这些系统是我们生态系统的核心元素，旨在改善肩部外科护理的核心组成部分——术前规划、植入设计和程序效率，以惠及护理链中的每个利益相关者。</p>
<h2>另见</h2>
<ul>
<li>五只我们更看好的股票，胜过肩部创新</li>
<li>现在购买的三只最佳蓝筹股</li>
<li>为什么 DLocal 是 2026 年值得关注的顶级新兴市场金融科技股票</li>
<li>每股收益计算器：如何计算 EPS</li>
<li>Nutanix 是否是 2025 年剩下的最佳反弹交易？设置显示是的</li>
<li>成长股：它们是什么，它们又不是些什么</li>
<li>Vertiv 回调：忽略噪音，购买数据</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNJ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNJ"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在肩部创新吗？</h2>
<p>在你考虑肩部创新之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而肩部创新并不在名单上。</p>
<p>虽然肩部创新目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

<p>Shoulder Innovations 的首席财务官 Jeffrey Points 以 14,576.75 美元购买了 995 股公司股票，增加了 1.90% 的持股比例。该交易已在 SEC 文件中披露。公司的股票在过去 52 周的价格范围为 10.92 美元至 17.94 美元，分析师对其给予了 “适度买入” 的评级，平均目标价格为 20.60 美元</p>

<p>Shoulder Innovations, Inc. (NYSE:SI - Get Free Report) CFO Jeffrey Points acquired 995 shares of the business's stock in a transaction dated Thursday, December 11th. The stock was purchased at an average price of $14.65 per share, with a total value of $14,576.75. Following the completion of the transaction, the chief financial officer directly owned 53,440 shares of the company's stock, valued at $782,896. This trade represents a 1.90% increase in their position. The purchase was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available at this hyperlink.</p>
<div class="lb-trans"><p>肩部创新公司（NYSE:SI - 获取免费报告）首席财务官杰弗里·波因茨于 12 月 11 日（星期四）购买了 995 股该公司的股票。股票的平均购买价格为每股 14.65 美元，总价值为 14,576.75 美元。交易完成后，首席财务官直接持有 53,440 股公司的股票，价值 782,896 美元。这笔交易代表了其持股比例的 1.90% 的增加。此次购买在提交给证券交易委员会的文件中披露，相关文件可通过此链接获取。</p>
</div><p>Get <strong>Shoulder Innovations</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>肩部创新</strong> 的提醒：</p>
</div><h2>Shoulder Innovations Price Performance</h2>
<div class="lb-trans"><h2>肩部创新价格表现</h2>
</div><ul>
<li>3 Mining Stocks Poised to Ride the Precious Metals Boom</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只矿业股票有望受益于贵金属热潮</li>
</ul>
</div><p>NYSE SI traded up $0.12 on Monday, hitting $14.49. The stock had a trading volume of 36,567 shares, compared to its average volume of 112,664. The business has a 50-day moving average of $13.43. Shoulder Innovations, Inc. has a 52-week low of $10.92 and a 52-week high of $17.94.</p>
<div class="lb-trans"><p>周一，NYSE SI 上涨 0.12 美元，达到 14.49 美元。该股票的交易量为 36,567 股，而其平均交易量为 112,664 股。该公司的 50 日移动平均线为 13.43 美元。肩部创新公司 52 周最低价为 10.92 美元，52 周最高价为 17.94 美元。</p>
</div><p>Shoulder Innovations (NYSE:SI - Get Free Report) last released its quarterly earnings results on Tuesday, November 11th. The company reported ($0.48) earnings per share for the quarter, missing the consensus estimate of ($0.37) by ($0.11). The firm had revenue of $11.76 million for the quarter, compared to analysts' expectations of $9.99 million. On average, research analysts anticipate that Shoulder Innovations, Inc. will post -0.56 EPS for the current year.</p>
<div class="lb-trans"><p>肩部创新（NYSE:SI - 获取免费报告）最近于 11 月 11 日（星期二）发布了季度财报。公司报告本季度每股收益为（0.48 美元），低于市场共识预期的（0.37 美元），差距为（0.11 美元）。该公司本季度的收入为 1176 万美元，而分析师预期为 999 万美元。研究分析师平均预计肩部创新公司本年度每股收益为-0.56 美元。</p>
</div><h2>Hedge Funds Weigh In On Shoulder Innovations</h2>
<div class="lb-trans"><h2>对肩部创新的对冲基金看法</h2>
</div><ul>
<li>MarketBeat Week in Review – 7/8 - 7/12</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 7/8 - 7/12</li>
</ul>
</div><p>Several institutional investors and hedge funds have recently made changes to their positions in the business. Federated Hermes Inc. bought a new stake in Shoulder Innovations in the third quarter worth $2,510,000. Board of Trustees of The Leland Stanford Junior University purchased a new position in shares of Shoulder Innovations in the third quarter worth about $170,000. Rhumbline Advisers purchased a new position in shares of Shoulder Innovations in the third quarter worth about $54,000. TimesSquare Capital Management LLC bought a new stake in shares of Shoulder Innovations in the 3rd quarter valued at about $4,799,000. Finally, Vanguard Group Inc. purchased a new stake in Shoulder Innovations during the 3rd quarter valued at about $1,836,000.</p>
<div class="lb-trans"><p>几家机构投资者和对冲基金最近对该公司的持仓进行了调整。Federated Hermes Inc.在第三季度购买了肩部创新的新股份，价值 251 万美元。斯坦福大学董事会在第三季度购买了肩部创新的新股份，价值约 17 万美元。Rhumbline Advisers 在第三季度购买了肩部创新的新股份，价值约 5.4 万美元。TimesSquare Capital Management LLC 在第三季度购买了肩部创新的新股份，价值约 479.9 万美元。最后，先锋集团在第三季度购买了肩部创新的新股份，价值约 183.6 万美元。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师评级上调和下调</h2>
</div><p>A number of brokerages have recently issued reports on SI. BTIG Research reiterated a &#34;buy&#34; rating and set a $23.00 price target on shares of Shoulder Innovations in a research report on Tuesday, September 9th. Piper Sandler reiterated an &#34;overweight&#34; rating and set a $18.00 target price on shares of Shoulder Innovations in a research report on Wednesday, November 12th. Wall Street Zen raised shares of Shoulder Innovations from a &#34;sell&#34; rating to a &#34;hold&#34; rating in a report on Saturday, October 11th. Jefferies Financial Group started coverage on shares of Shoulder Innovations in a research report on Monday, August 25th. They set a &#34;buy&#34; rating and a $19.00 price objective on the stock. Finally, Zacks Research upgraded shares of Shoulder Innovations to a &#34;hold&#34; rating in a research report on Tuesday, August 26th. Five investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Shoulder Innovations presently has an average rating of &#34;Moderate Buy&#34; and an average target price of $20.60.</p>
<div class="lb-trans"><p>多家券商最近对 SI 发布了报告。BTIG 研究在 9 月 9 日的研究报告中重申了 “买入” 评级，并设定了 23.00 美元的目标价。Piper Sandler 在 11 月 12 日的研究报告中重申了 “增持” 评级，并设定了 18.00 美元的目标价。华尔街 Zen 在 10 月 11 日的报告中将肩部创新的评级从 “卖出” 上调至 “持有”。杰富瑞金融集团在 8 月 25 日的研究报告中开始覆盖肩部创新的股票，设定了 “买入” 评级和 19.00 美元的目标价。最后，Zacks 研究在 8 月 26 日的研究报告中将肩部创新的评级上调至 “持有”。五位投资分析师对该股票给予了 “买入” 评级，一位给予了 “持有” 评级，一位给予了 “卖出” 评级。根据 MarketBeat 的数据，肩部创新目前的平均评级为 “适度买入”，平均目标价为 20.60 美元。</p>
</div><ul>
<li>New Theme Park Powerhouse: Merger Creates Industry-Leading Stock</li>
</ul>
<div class="lb-trans"><ul>
<li>新主题公园强者：合并创造行业领先股票</li>
</ul>
</div><p><strong>View Our Latest Stock Report on SI</strong></p>
<div class="lb-trans"><p><strong>查看我们最新的 SI 股票报告</strong></p>
</div><h2>Shoulder Innovations Company Profile</h2>
<div class="lb-trans"><h2>肩部创新公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>We are a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. We currently offer advanced implant systems for shoulder arthroplasty. These systems are a core element of our ecosystem, which we designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain.</p>
<div class="lb-trans"><p>我们是一家商业阶段的医疗技术公司，专注于转变肩部外科护理市场。我们目前提供用于肩关节置换术的先进植入系统。这些系统是我们生态系统的核心元素，旨在改善肩部外科护理的核心组成部分——术前规划、植入设计和程序效率，以惠及护理链中的每个利益相关者。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than Shoulder Innovations</li>
<li>The 3 Best Blue-Chip Stocks to Buy Now</li>
<li>Why DLocal Is the Top Emerging Market Fintech Stock to Watch for 2026</li>
<li>Earnings Per Share Calculator: How to Calculate EPS</li>
<li>Is Nutanix the Best Comeback Trade Left in 2025? The Setup Says Yes</li>
<li>Growth Stocks: What They Are, What They Are Not</li>
<li>The Vertiv Pullback: Ignore the Noise, Buy the Data</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过肩部创新</li>
<li>现在购买的三只最佳蓝筹股</li>
<li>为什么 DLocal 是 2026 年值得关注的顶级新兴市场金融科技股票</li>
<li>每股收益计算器：如何计算 EPS</li>
<li>Nutanix 是否是 2025 年剩下的最佳反弹交易？设置显示是的</li>
<li>成长股：它们是什么，它们又不是些什么</li>
<li>Vertiv 回调：忽略噪音，购买数据</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNJ" alt="" original-src="https://www.marketbeat.com/scripts/InsiderTradesChart.ashx?Prefix=NYSE&amp;Symbol=SI"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Shoulder Innovations Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在肩部创新吗？</h2>
</div><p>Before you consider Shoulder Innovations, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑肩部创新之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Shoulder Innovations wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而肩部创新并不在名单上。</p>
</div><p>While Shoulder Innovations currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然肩部创新目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Shoulder Innovations（NYSE:SI）的首席财务官购买了价值 14,576.75 美元的股票